EDGAR Filing Documents for 0001193125-20-072305

Form 8-K - Current report:

SEC Accession No. 0001193125-20-072305

Filing Date

2020-03-13

Accepted

2020-03-13 08:12:32

Documents

Period of Report

2020-03-13

Items

Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	d859109d8k.htm	8-K	19444
2	EX-99.1	d859109dex991.htm	EX-99.1	18298
3	GRAPHIC	g859109g0312064948028.jpg	GRAPHIC	4527
	Complete submission text file	0001193125-20-072305.txt		45314

Mailing Address 2155 PARK BOULEVARD PALO ALTO CA 94306

Business Address 2155 PARK BOULEVARD PALO ALTO CA 94306 650-279-9845

Eiger BioPharmaceuticals, Inc. (Filer) CIK: 0001305253 (see all company filings)

IRS No.: 361004130 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36183 | Film No.: 20710767
SIC: 2836 Biological Products, (No Diagnostic Substances)